Table 4. Relevant GO biological processes in blood as affected by selection for RFI.
GO terma | Genesb | |
---|---|---|
Overexpressed genes in low RFI line compared with high RFI line | ||
GO:0006414 | Translational elongation | RPSA, EEF1A1, RPL14, RPL15, RPL35, RPL23A, SELT, RPS3, RPS25, RPS18, RPL6, RPS13, RPL10, RPL10A, RPS21, UBA52, RPS23 |
Underexpressed genes in low RFI line compared with high RFI line | ||
GO:0006952 | Defense response | KYNU, NMI, FGR, LY86, CCR1, CLU, TLR1, TLR2, CXCR2, PRDX1, IL10, IL10RB, BCL2, TAP1, CSF3R, NFATC4, CD24, THBS1, BLNK, F12, TLR10, PTGER3, LY96, BECN1, HCK, IL1RN, HLA-C, C4BPB, HLA-B, CD40, C4BPA, STAT3, CD84, CD83, CD55, CD19, HIST2H2BE, CLEC7A, CLEC5A, CD14 |
GO:0045321 | Leukocyte activation | ZBTB32, BST2, TLR1, TLR2, CXCR2, CD40, TPD52, SKAP2, IL10, CBLB, PKNOX1, PSEN1, ULBP1, BCL2, BCL11A, MS4A1, ADAM17, BCL6, CLEC7A, CD24, SYK, BLNK, ADAM9 |
GO:0050727 | Regulation of inflammatory response | F12, ADRB2, PTGS2, SERPINF1, TGM2, CMA1, BCL6, JAK2, CD24, IL10 |
GO:0044092 | Negative regulation of molecular function | NF1, PKIG, NPR3, PKIA, PROX1, PDCD4, PSMB8, PSMB9, SH3BP5, SPRY2, ADRB2, PSEN1, PSME2, CDKN2D, RGS4, PSMA3, UBC, SORT1, JAK2, UBE2D1, BUB3, DHCR24 |
GO:0019882 | Antigen processing and presentation | HLA-H, ULBP1, HLA-DRB3, HLA-A, ERAP1, HLA-C, CD1A, HLA-B, HLA-DOB, PSMB8, PSMB9 |
GO:0006916 | Anti-apoptosis | BECN1, SPHK1, CLU, BIRC3, ANXA4, IL10, TNFSF13B, PSEN1, BCL2, CDKN2D, TGM2, UBC, ADAM17, THBS1, DHCR24 |
GO:0002684 | Positive regulation of immune system process | CLU, TLR2, C4BPB, CD40, C4BPA, CD83, CBLB, CD55, CD19, TNFSF13B, PSEN1, ADAM17, BCL6, CD24, CLEC7A, THBS1, SYK |
GO:0030155 | Regulation of cell adhesion | VAV3, GSN, BCL2, NF1, CCDC80, TGM2, BCL6, JAK2, CD24, THBS1, TPM1, ADAM9 |
aGene ontology (GO) identification number and term of the biological process. Benjamini-Hochberg adjusted P-value varied from 0.1 and 8.10−05.
bUnique genes included in each pathway.